Year Established :
1985
Total Assets(USD) :
More than 1000,000,000
Total Number of Staff :
more than 500
Other Competitive Advantages :
The company now employs more than 400 people and all the senior executives have acquired their senior technical titles. It has modern GMP-compliant workshops with a usable area of 6,000 square meters, and various advanced manufacturing equipment and test apparatus imported from countries including the U.S.A., Germany and Japan, which have provided technical assurance for the quality of the existing products and the R&D of new products.The company passed the acceptance inspection of China Certification Committee for Quality Mark and obtained ISO9001 Quality System Certificate. The quantity and quality of its leading products including Human Albumin and Human Immunoglobulin head the list of domestic blood product manufacturers, and its products are well sold in 30 domestic provinces, municipalities and autonomous regions, and some of them have successfully entered the international market.
Patents and Copyrights :
The ‘preservative-free dual viral inactivation process’ developed and invented independently by the company has obtained a patent certificate issued by the United States Patent and Trademark Office, with Patent No. US006338849B1, a patent certificate issued by IP Australia, with Patent No. 756017, and a patent certificate issued by the State Intellectual Property Office of P. R. China, with Patent No. ZL98112108.X.
Business Type :
Manufacturer,Trading Company
Annual Turnover(USD) :
10,000,000 To 14,999,999
Main Sales Markets :
Central/South America,Eastern Europe,Asia,Middle East,Africa
Main Product Categorise :
Finished Dosage,Bio Products
Product Range :
Human albumin
Human immunoglobulin for intravenous administration
Human hepatitis B immunoglobulin
Human histamine immunoglobulin
Human immunoglobulin
Human rabies immunoglobulin
Human tetanus immunoglobulin
Eighteen years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
